GDNF in treatment of Parkinson's disease: response to editorial-Reference-Cited by-同舟云学术

GDNF in treatment of Parkinson's disease: response to editorial

Published:2006-03 Issue:3 Volume:5 Page:200-202
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Lang Anthony E,Langston J William,Stoessl A Jon,Brodsky Matthew,Brooks David J,Dhawan Vijay,Elias William J,Lozano Andres M,Moro Elena,Nutt John G,Stacy Mark,Turner Dennis,Wooten G Frederick

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference7 articles.

1. The hard way to a Bill of Rights;The Lancet Neurology;Lancet Neurol,2005

2. Randomised controlled trial of intraputamenal GDNF infusion in Parkinson's disease;Lang;Ann Neurol,2006

3. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease;Gill;Nature Med,2003

4. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor;Slevin;J Neurosurg,2005

5. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD;Nutt;Neurology,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restorative cell and gene therapies for Parkinson's disease;Handbook of Clinical Neurology;2023

2. Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis;The Biology of Glial Cells: Recent Advances;2022

3. Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson’s Disease. A Systematic Review;Frontiers in Aging Neuroscience;2021-02-24

4. Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery;Pharmaceuticals;2020-11-16

5. Parkinson disease and growth factors — is GDNF good enough?;Nature Reviews Neurology;2019-04-04